Comment on Ramsden et al.

British Journal of Nutrition

Volumn 106, Issue 6, 2011, Pages 958-

  Clifton, Peter ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LINOLENIC ACID; POLYUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; FAT INTAKE; ISCHEMIC HEART DISEASE; LETTER; PRIMARY PREVENTION; RISK BENEFIT ANALYSIS; RISK REDUCTION; SECONDARY PREVENTION; TREATMENT DURATION; TREATMENT OUTCOME; HEART INFARCTION; HUMAN; NOTE;

CORONARY DISEASE; DIETARY FATS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; MYOCARDIAL INFARCTION;

EID: 80555156792     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511004466     Document Type: Letter

References (2)

1. Ramsden CE, Hibbeln JR, Majchrzak SF, et al. (2010) n-6 Fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: A meta-Analysis of randomised controlled trials. Br J Nutr 104, 1586-1600.
2. Hooper L, Summerbell CD, Higgins JP, et al. (2001) Dietary fat intake and prevention of cardiovascular disease: Systematic review. BMJ 322, 757-763. (Pubitemid 32269648)